Chong Chin Sieng is a lecturer at the Department of Economics, Faculty of Business and Economics, Universiti Malaya. His research interests include macroeconomics, financial markets and real estate. In addition, he has been involved in public health research. He teaches subjects such as money and banking, microeconomics, mathematical economics and principle of economics.

Professor Dr Maznah Dahlui is a Public Health Medicine Specialist who had served for several years with the Ministry of Health, Malaysia and was a General Practitioner before becoming an academician in the University of Malaya in 2007. Her specialty is health economics, with a major interest in the economic evaluation of health programs. She had evaluated many of the country’s health policies and programs, working with various ministries in Malaysia such as Ministry of Health, Ministry of Labor, Ministry of Science and Technology and Prime Minister’s Department. She has good linkages with international institutions such as the UNFPA, UNESCO, World Bank, WHO which have led to several consultancy projects centered on the evaluation and monitoring of health programs. Maznah’s research interest extends to cancer screening, infectious diseases such as HIV and Hepatitis C, mental health and obesity prevention; applying the economic evaluation approaches. She has been actively engaging NGOs (such as Breast Cancer Welfare Society and MAKNA) and the communities (the urban poor community and rural populations) for breast cancer screening and combating chronic diseases such as hypertension and diabetes. Her international research experiences include working with collaborators from Sanger Institute, University Cambridge, United Kingdom on the Salt Reduction Study, Kirby Institute, University of New South Wales, Australia on Return of Investment of Harm Reduction Program, University of Usmanu Danfodia, Sokoto, Nigeria on sexual reproductive health issues under the auspices of the Africa-Asia Development University Network (AADUN), and several others. Maznah has been the Regional Director of APACPH (Asia Pacific Academic Consortium for Public Health) since 2013 and used this as an avenue for her to initiate research collaborations on community obesity prevention with several of the 47 active APACPH member institutions. With the backing of her university, in 2012 the APACPH Secretariat was successfully transferred to the University of Malaya where she had been the Vice President (Admin) until now. Her appointment as the Chair for the National Clearinghouse for Adolescent Health in Malaysia and as exclusive member of Technical Advisory Committee of Health Technology Economic Evaluation (TACHTEE), Malaysia are acknowledgments of her expertise and close working relationship with the Ministry of Health. Dr Maznah has several academic appointments by various local and international universities including as an Adjunct Professor at University of Airlangga (UA), Surabaya, Indonesia. Dr Maznah considers UA as her second workplace where she highly appreciates the shared experiences in teaching, research and publications with the faculty at Fakultas Public Health, UA. Her outstanding contributions to public health in such a short span of time contributed significantly to her election as a Fellow of the prestigious Academy Science Malaysia (2021), Fellow of Public Health Medicine Specialist Association (2019), Fellow of Public Health Physician Malaysia (2018) and Distinguished Fellow of Faculty of Public Health, Royal College of Physicians, United Kingdom (2016). Maznah’s leadership capabilities has been acknowledged by the university with her appointment as the head of Department of Social and Preventive Medicine (2011 to 2016), and as the Deputy Dean (Post-Graduate) of Faculty of Medicine (2016 to 2020). She was the senate representative of University Malaya for 2016 to 2018 and is sitting in Curriculum Review Committee of the university since 2019. Currently, Dr Maznah is the Head, Department of Research Development and Innovation at University Malaya Medical center, while leading the Case-Mix System implementation at the hospital. Dr Maznah is currently active in contributing her expertise as a Public Health specialist to curb Covid 19 pandemic where she is helping the country to assess the economic implications of the pandemic to the healthcare system and country at large. She is also in the Independent Advisory Committee for Covid 19 Vaccination of the country.

Associate Professor Dr. Chen Yeng is an expert in cancer biomarker discovery, biosensor development, and natural therapeutics, with a multidisciplinary approach that bridges nanotechnology, molecular biology, and biomedicine. Her expertise is particularly evident in her work on innovative diagnostic technologies and personalized therapeutic solutions, targeting both cancer and infectious diseases.  Her research interests span several cutting-edge areas. One of her primary focuses is the identification and characterization of cancer biomarkers, particularly through novel approaches targeting at immunogenic host proteins. This line of research explores how immunogenic proteins’ interventions might modulate cancer risk, representing an innovative intersection of microbiology, proteomics, and oncology.  Dr. Chen is also deeply engaged in developing advanced diagnostic tools, including nanobiosensors with enhanced sensitivity and specificity. These devices, designed to detect critical biomarkers such as those associated with tuberculosis, blood clotting disorders, and oral cancer, are transformative for early disease detection. Her work in biosensors, utilizing materials like gold nanoparticles and zinc oxide nanolayers, has set new standards in diagnostic accuracy and reliability.  Another cornerstone of her research is the study of natural plant extracts for therapeutic applications, particularly in cancer treatment. She investigates the biochemical and pharmacological properties of these extracts, focusing on their mechanisms of action, such as inducing apoptosis, causing cell cycle arrest, and promoting mitochondrial dysfunction in cancer cells. Her exploration of natural products' roles in modulating microRNAs further highlights her innovative approach to cancer research.  Dr. Chen’s expertise also extends to the antioxidant, hepatoprotective, and genoprotective properties of herbal compounds, offering potential preventive and therapeutic solutions for chronic diseases. These studies underline her commitment to sustainable and natural approaches in healthcare.  Her contributions to genomics and proteomics, particularly in large-scale screening for biological markers, further demonstrate her role as a leader in translating complex biological data into meaningful clinical applications. By combining her deep understanding of molecular biology with a focus on real-world impact, Dr. Chen has established herself as a pioneer in her field.  Dr. Chen’s academic influence is demonstrated by her impressive h-index of 28 (ResearchID) and 39 (Scopus), with over 4,500 citations to her name. Her extensive publication record spans high-impact journals, contributing significantly to advancements in dentistry, oncology, and biomedical engineering. She is recognized as a top scientist in Malaysia, ranking among the leading figures in dentistry according to the AD Scientific Index. As a respected peer reviewer for prestigious journals, including Coordination Chemistry Reviews, Periodontal 2000, Biosensors and Bioelectronics, and Cancer Letters, Dr. Chen plays a critical role in maintaining the quality of research within her fields of expertise. Her contributions extend to academic leadership, where she had supervised and graduated over 20 postgraduate students, including 11 PhD candidates, nurturing the next generation of scientific leaders. Her leadership in dental education accreditation has further solidified her impact on academic excellence. She has played pivotal roles in the reaccreditation of dental programs at the University of Malaya and other institutions, ensuring that these programs meet global standards. Through her commitment to interdisciplinary collaboration, Dr. Chen has partnered with industry leaders to translate research findings into practical healthcare solutions, such as rapid diagnostic tools and personalized treatments. These collaborations exemplify her ability to bridge scientific discovery with real-world applications. In summary, Dr. Chen’s expertise and research interests reflect a holistic approach to biomedical science, integrating cutting-edge technologies with sustainable practices. Her work not only pushes the boundaries of knowledge in cancer research and diagnostics but also has the potential to transform patient care and public health globally.